Autolus Therapeutics AUTL
NASDAQ AUTL
$2.24 -0.05 (-2.18%)
As of: Sep 4, 2026 · 3:59 PM EDT

Autolus Therapeutics (AUTL) FCF Margin Growth (1y) (2018 - 2025)

Analysis

Autolus Therapeutics (AUTL) FCF Margin Growth (1y) (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -89.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -1,183.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 26,102.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 869.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 769.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 811.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 19,111.00
10 Autolus Therapeutics 594.86 Mn 393.23 Mn 25.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 16.89 Mn
Mar 31, 2025 -52,608.00
Mar 31, 2024 316,198.00
Sep 30, 2023 -869,733.00
Mar 31, 2023 1.80 Mn
Sep 30, 2022 1.48 Mn
Mar 31, 2022 -697,839.00
Sep 30, 2021 -651,748.00
Jun 30, 2021 684,542.00
Mar 31, 2021 -611,007.00
Jun 30, 2020 -691,188.00
Mar 31, 2020 -675,503.00
Jun 30, 2019 -55,619.00
Dec 31, 2018 -128,973.00